Interpace Biosciences (IDXG) Reports Q3 EPS of $0.31

Interpace Biosciences (OTC: IDXG) reported Q3 EPS of $0.31. Revenue for the quarter came in at $12.3 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Citi raises Super Micro Computer price target to $39
• Chicago Atlantic Real Estate Finance (REFI) PT Lowered to $16 at Citizens Post Q2 Results
• Deutsche Bank Upgrades Entegris Inc (ENTG) to Buy